Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 2Hepatitis, Chronic 1Hepatitis C 1Carcinoma, Transitional Cell 1Carcinoma, Hepatocellular 1BRCA1/2 Mutation 1

Interventions

rocakinogene sifuplasmid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis, Chronic × rocakinogene sifuplasmid × 1 year × Clear all
NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

National Cancer Institute (NCI)

Phase 1 Active not recruiting
33 enrolled
Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡